Anastomotic Leak
1
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Johnson & JohnsonNEW BRUNSWICK, NJ
1 programSpanish National Registry of ANAstomotic Leakage in CAncer of the REctum (ANACARE)N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Innovation PharmaceuticalsStream™ Platform
MerilThree-row circular stapler
Johnson & JohnsonSpanish National Registry of ANAstomotic Leakage in CAncer of the REctum (ANACARE)
Clinical Trials (3)
Total enrollment: 2,369 patients across 3 trials
Economic Evaluation of Stream™ Platform
Start: Dec 2023Est. completion: Jun 2026215 patients
Phase 3Active Not Recruiting
THREE-row Circular STAPLER in Low Anterior Resection for Rectal Cancer
Start: Apr 2019Est. completion: Oct 2020154 patients
N/AUnknown
NCT02634112Johnson & JohnsonSpanish National Registry of ANAstomotic Leakage in CAncer of the REctum (ANACARE)
Spanish National Registry of ANAstomotic Leakage in CAncer of the REctum (ANACARE)
Start: Jan 2016Est. completion: Nov 20162,000 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.